骨髓瘤 的英文怎麼說

中文拼音 [gǔsuǐliú]
骨髓瘤 英文
myeloid tumor
  • 骨 : 骨名詞1 （骨頭） bone2 （物體內部的支架） framework; skeleton 3 （品質; 氣概） character; spirit ...
  • 髓 : 名詞1. [生理學] （骨髓; 像骨髓的東西） marrow 2. [植物] （莖的中心部分） pith
  • 瘤 : 名詞（瘤子） tumour
  • 骨髓 : marrow; keest; medulla ossium; bone marrow骨髓白細胞 myeloplast; 骨髓病 myelopathy; myelopthy; os...
  1. In addition, the ability of mscs to make asparagine might be decreased by cancer drugs already known to disrupt msc activity

    另外那些已經知道的破壞骨髓間充質幹細胞活性的腫瘤藥物應該可以降低骨髓間充質幹細胞產生天冬酰胺的能力。
  2. The most frequent mistreating is curettage for a malignant lesion based on a misdiagnosis, such as osteomyelitis, fibrodysplacia, gct, cyst, etc

    對惡性骨腫瘤給予刮除植骨.該類錯誤治療的原因多是誤診為骨髓炎、纖維結構不良、骨巨細胞瘤或囊腫等。
  3. The lesson to be learned from the present case is that a transient plasma cell dyscrasia may present like multiple myeloma in the setting of heavy immunosuppression after organ transplantation

    從這個病例中得到的教訓是，在器官移植后的嚴重免疫抑制狀況下，暫時性血細胞惡液質可以有類似多發性骨髓瘤樣的表現。
  4. The changes of bone mineral density in patients with multiple myeloma

    多發性骨髓瘤患者骨密度的改變
  5. The most frequent cancer diagnosis was multiple myeloma ( in 63 % )

    這些病人中最常見的疾病是多發性骨髓瘤（ 63 % ） 。
  6. Clinical and prognosis analysis of multiple myeloma patients with renal dysfunction

    多發性骨髓瘤腎功能不全患者臨床與預後分析
  7. Clinical characteristics and relational factors analysis of multiple myeloma with renal involvement

    多發性骨髓瘤腎損害臨床特徵及有關因素分析
  8. Anticancer actiity of this agent has been reported in arious malignant disorders, including multiple myeloma and myelodysplastic syndrome

    它對多種腫瘤具有抗腫瘤活性，其中包括骨髓瘤和骨髓增生異常綜合征。
  9. Lab - grown cancer cells treated with sildenafil showed similar results, as did tissue samples taken from 14 head and neck cancer and multiple myeloma patients

    昔多芬在實驗室培養的腫瘤細胞上可見到同樣效果，同時，在14個頭頸部腫瘤和多發性骨髓瘤患者的組織樣品中也可以出現同樣的效果。
  10. " on the basis of our experience, we suggest that the standard of care for patients with smoldering multiple myeloma should be close follow - up eery few months, " the researchers conclude

    在我們的研究基礎上，我們建議無癥狀多發性骨髓瘤患者的監護標準應每隔幾個月進行一次嚴密隨訪。研究者總結說。
  11. In most cases of chronic urticaria, an underlying trigger is not found. hodgkin ' s disease may be accompanied by urticaria. cold urticaria with cryoglobulinemia is seen in multiple myeloma

    在大多數慢性蕁麻疹患者，找不到觸發原因。霍傑金氏病可伴有蕁麻疹；冷球蛋白血癥引起的蕁麻疹見于多發性骨髓瘤。
  12. Now it has been found the recruitment and homing of circulating endothelial cells ( cecs ) or their progenitors ( ceps ) released from the bone marrow is very important in tumor angiogenesis. we detected the cecs and ceps in 64 pb ( peripheral blood ) of tumor patients. we found the amount of cecs and ceps is higher in tumor patients than normal controls

    本項目應用流式細胞法對64例腫瘤患者及15例正常人，外周血中的循環血管內皮細胞（ circulatingendothelialcell ， cec ）以及骨髓來源的循環血管內皮前體細胞（ circulalingendothelialprecursor ， cep ）進行了檢測，證實了外周血中cec / cep的存在，發現腫瘤患者cec / cep含量高於正常對照組，提示腫瘤患者體內存在血管內皮及其前體細胞的動員。
  13. Of the 12 nonfunctional adrenal tumors, all of which presented as adrenal incidentalomas, four were cortical adenoma, three were myelolipoma, two were ganglioneuroma, one was an adrenal cyst, one was an adrenocortical carcinoma, and one was a metastatic carcinoma

    另在12位不具功能性的腎上線腫瘤皆為意外發現之腫瘤，其中4位為腎上腺腺瘤， 3位為腎上腺骨髓脂肪瘤， 2位為腎上腺神經結神經細胞瘤， 1位為腎上腺囊腫， 1位為腎上腺惡性腫瘤， 1位為轉移性腫瘤。
  14. Drugs that target a single switch have transformed the treatment of some patients with certain cancers - - for instance, gleevec and chronic myelogenous leukemia

    以單一的調空點為靶點的藥物已經轉變為某些腫瘤患者的治療方法。比如，格列衛和慢性骨髓性白血病。
  15. It has been reported that " glivec " for the treatment of gastrointestinal stromal tumour and chronic myeloid leukaemia has been classified by the hospital authority ( ha ) as first - line drug, and patients who have to take the drug and have financial difficulties will be referred to apply for drug subsidy from the samaritan fund

    據報，醫院管理局（醫管局）將治療胃腸基質瘤及慢性骨髓性白血病的藥物加以域定為第一線藥物，並會安排須服用該藥物而有經濟困難的病人申請撒瑪利亞基金的藥費資助。
  16. Study on ft - raman spectroscopy of puc18 dna

    骨髓瘤細胞的抑制作用研究
  17. This article reviews the latest progress of nucleoside analogues on the treatment of multiple myeloma in recent years and introduces the mechanism of action, preclinical study and clinical application of fludarabine and gemcitabine in treating multiple myeloma

    綜述了近年來核苷類似物治療多發性骨髓瘤的最新研究進展，介紹核苷類似物氟達拉濱和吉西他濱治療多發性骨髓瘤的作用機制、基礎研究和臨床應用。
  18. As a proteasome inhibitor, bortezomib has shown inhibition on cell proliferation, inducing cell apoptosis, inhibition of cell adhension and inhibition of tumor angiogenesis for multiple myeloma cells

    摘要硼替佐米作為一種蛋白酶抑制劑，對多發性骨髓瘤細胞表現出抑制細胞生長、誘導腫瘤細胞凋亡、抑制細胞粘附、抑制腫瘤血管生成等作用，同時對血液系統其他惡性腫瘤具有顯著的作用。
  19. New york ( reuters health ) jun 20 - the proportion of plasma cells in bone marrow and the serum monoclonal protein leel at diagnosis influence the risk that smoldering ( asymptomatic ) multiple myeloma will progress to symptomatic disease, new research suggests

    紐約路透通訊社健康欄6月20日訊：最新研究發現，骨髓血漿細胞和血清單克隆蛋白水平的比例會影響無癥狀性多發性骨髓瘤發展為有癥狀性骨髓瘤的風險。
  20. Methods : the balb / c mouse is immunized with gene recombinant antigen p24 for four times in 2 months. the spleen cells of immunized mouse is hybridized with sp2 / 0 by peg, and the positive cell clones secreting the antibody to antigen p24 are detected by indirect elisa. through three clonings less diversed anti - p24 hybridoma cells are gained

    方法：基因工程p24抗原免疫小鼠4次，歷時2個月，取脾細胞與骨髓瘤細胞株sp2 0 ，用peg融合， hat選擇培養和間接elisa篩選分泌抗p24抗體陽性的雜交瘤細胞，三次克隆化后得穩定分泌抗p24抗體的雜交瘤細胞株。
分享友人
分享到 Line

分享到臉書